[Anti-arrhythmic drugs].
D000404:Ajmaline / Q000494:pharmacology; D000889:Anti-Arrhythmia Agents / Q000145:classification; D001949:Bretylium Compounds / Q000494:pharmacology; D002395:Catecholamines / Q000494:pharmacology; D002463:Cell Membrane Permeability / Q000187:drug effects; D004071:Digitalis Glycosides / Q000494:pharmacology; D006325:Heart Atria / Q000187:drug effects; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D010096:Oxprenolol / Q000494:pharmacology; D010672:Phenytoin / Q000494:pharmacology; D011342:Procainamide / Q000494:pharmacology; D011802:Quinidine / Q000494:pharmacology
D000889:Anti-Arrhythmia Agents; D001949:Bretylium Compounds; D002395:Catecholamines; D004071:Digitalis Glycosides; D000404:Ajmaline; D010096:Oxprenolol; D010672:Phenytoin; D011802:Quinidine; D011342:Procainamide
Leki antarytmiczne.